Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F21%3A00074349" target="_blank" >RIV/65269705:_____/21:00074349 - isvavai.cz</a>

Alternative codes found

RIV/00216224:14110/21:00120995

Result on the web

<a href="https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1861274?journalCode=ilal20" target="_blank" >https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1861274?journalCode=ilal20</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/10428194.2020.1861274" target="_blank" >10.1080/10428194.2020.1861274</a>

Result language

angličtina

Original language name

Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients

Original language description

According to European Leukemia Network (ELN) recommendations, real-time quantitative PCR (qRT-PCR) is a conventional strategy for long-term BCR-ABL1 transcript monitoring in patients with chronic myeloid leukemia (CML) both during tyrosine kinase inhibitor (TKI) therapy and its discontinuation [1-5]. However, with the new Regulation (EU) 2017/746 coming, health institutions will have to start using CE-marked IVD (CE-IVD) devices (including kits, reagents, calibrators, etc.) for analyses. Thus, commercial CE-IVD tests will also enter into routine CML diagnostics in the near future. The aim of our work was to compare two CE-IVD tests with the conventional ELN method to monitor CML patiens&apos; BCR-ABL1 transcripts in routine practice.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30205 - Hematology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2021

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Leukemia &amp; Lymphoma

ISSN

1042-8194

e-ISSN

—

Volume of the periodical

62

Issue of the periodical within the volume

5

Country of publishing house

GB - UNITED KINGDOM

Number of pages

4

Pages from-to

1239-1242

UT code for WoS article

000603914300001

EID of the result in the Scopus database

2-s2.0-85098516810